Michael Tymianski, M.D., Ph.D.

Neurosurgery Toronto Western Hospital, University of Toronto 
Stroke, NMDA receptors, TRP channels
"Michael Tymianski"
Mean distance: 19.48 (cluster 40)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hill MD, Goyal M, Menon BK, et al. (2020) Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet (London, England)
Gondard E, Teves L, Wang L, et al. (2019) Deep Brain Stimulation rescues memory and synaptic activity in a rat model of global ischemia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Sun X, Garman D, Tymianski M. (2019) Abstract 80: The Experimental Neuroprotective Drug Na1 Does Not Interfere With the Fibrinolytic Activities of Alteplase or Tenecteplase Stroke. 50
Ballarin B, Cui H, Teves LM, et al. (2019) Abstract 25: Promoting Recovery After Stroke by Manipulating NMDA Receptor-Associated Signalling in the Early Post Stroke Phase Stroke. 50
Bernhardt J, Zorowitz RD, Becker KJ, et al. (2018) Advances in Stroke 2017. Stroke
Ballarin B, Tymianski M. (2018) Discovery and development of NA-1 for the treatment of acute ischemic stroke. Acta Pharmacologica Sinica. 39: 661-668
Wu QJ, Tymianski M. (2018) Targeting NMDA receptors in stroke: new hope in neuroprotection. Molecular Brain. 11: 15
Mayor D, Tymianski M. (2017) Neurotransmitters in the mediation of cerebral ischemic injury. Neuropharmacology. 134: 178-188
Bosetti F, Koenig JI, Ayata C, et al. (2017) Translational Stroke Research: Vision and Opportunities. Stroke
Tymianski M. (2017) Combining Neuroprotection With Endovascular Treatment of Acute Stroke: Is There Hope? Stroke
See more...